Consequently, therapy or symptom control of this asthma endotype still represents an unmet medical need and led to detailed research efforts to untangle the relationship between IL-17, Th17 cells, neutrophils, and corticosteroid resistance in asthma. This evidence concerns the gene IL17A and asthma.